Dexamethasone
-
Central Government Allows Covid-19 Low Cost Medicine Dexamethasone for Use in India
The Central government has approved the usage of low-cost steroid drug dexamethasone to treat the covid-19 patients in India with moderate and severe symptoms. British clinical trials had earlier found Dexamethasone to be effective against severely ill patients. The drug is approved to be used…
#Top on Krishi Jagran
We're on WhatsApp! Join our WhatsApp group and get the most important updates you need. Daily.
Join on WhatsAppSubscribe to our Newsletter. You choose the topics of your interest and we'll send you handpicked news and latest updates based on your choice.
Subscribe NewslettersLatest feeds
- DBT & BRIC Launches One Day One Genome Initiative to Unlock Microbial Potential
- INDO AGRI-FUTURE FOOD 2024: A Platform for Innovation, Trade, and Networking
- Ayushman Bharat Vay Vandana Card: Revolutionizing Senior Citizen Healthcare with Free Treatment for All
- Odisha Govt and ICRISAT Launch Compendium of Regenerative Agriculture to Transform Farming Practices
- Nauni Varsity’s Vegetable Varieties Recognized Nationally for Outstanding Performance
- Sesame Farming: Boost Yields and Health with Improved Varieties
- ICSI CSEET November 2024 Result Announced; Here's the Direct Link
- Tomato Prices Fall 22.4% in a Month as Supply Improves Nationwide: Govt
- Delhi Chokes as AQI Hits 457: See What's Allowed and What's Not Under GRAP Stage-IV Restrictions
- Nauni University Launches Agri Incubation Center Under Public-Private Partnership